https://www.selleckchem.com/pr....oducts/atezolizumab.
001 and P0.001). A multivariable regression model found that patients with high levels of vaspin were approximately 1.85-fold (odds ratio for per unit increase 1.85, 95% confidence interval 1.43-2.55; P0.001) more likely to experience DR, and 3.76-fold (odds ratio for per unit increase 3.76, 95% confidence interval 2.05-6.55; P0.001) more likely to experience VTDR. The predictive value of vaspin was stronger in women than in men. Higher vaspin serum levels were associated with an increased risk of DR and VDTR in patient
Like
Comment
Share
